Shingrix crashes for GlaxoSmithKline as vaccination slows amid COVID-19

หน้าแรก / News / Shingrix crashes for GlaxoSmithKline as vaccination slows amid COVID-19

https://www.fiercepharma.com/pharma/shingrix-crashed-for-glaxosmithkline-as-vaccination-slows-amid-covid-19

Recent News

Time to take your shot, pharma: Pandemic offers best chance to reframe the conversation, brand expert says

With U.S elections nearing, European pharma giants brace for potential pricing action: analysts

Influenza-Flu: Study Shows that Targeting Nasal Bacteria Helps to Block Flu Transmission

COVID-19 Herd Immunity is Impractical and Disastrous According to New Study Plus Emerging Studies Indicate Immunity is Short-lived

COVID-19 Updates: World In Crisis, UK Reports 6,000 New Cases in 24 Hours, Spain Ropes In Army to Help, India Facing Healthcare Catastrophe

เกี่ยวกับเรา

In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.
In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

อ่านเพิ่มเติม